High-dose rifampicin to treat tuberculosis infection: potential and pitfalls

被引：0
|
作者：
Ryckman, Theresa S. [1 ]
Salazar-Austin, Nicole [2 ]
机构：
[1] Johns Hopkins Sch Med, Div Infect Dis, Baltimore, MD 21230 USA
[2] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD 21230 USA
来源：
LANCET RESPIRATORY MEDICINE | 2024年 / 12卷 / 06期
关键词：
D O I：
10.1016/S2213-2600(24)00107-3
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：420 / 421
页数：2
相关论文
共 50 条
  • [21] Neuroprotective potential of high-dose biotin
    McCarty, Mark F.
    DiNicolantonio, James J.
    MEDICAL HYPOTHESES, 2017, 109 : 145 - 149
  • [22] POTENTIAL COMPLICATIONS OF HIGH-DOSE EPINEPHRINE
    KARCH, SB
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (05): : 656 - 656
  • [23] Rifampicin nanocrystals: Towards an innovative approach to treat tuberculosis
    Curo Melo, Katherine Jasmine
    Bazan Henostroza, Mirla Anali
    Lobenberg, Raimar
    Bou-Chacra, Nadia Araci
    MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2020, 112
  • [24] Hepatic Safety of High-Dose Rifampicin for Tuberculosis Treatment in TB/HIV Co-infected Patients: A Randomized Clinical Trial
    Sanni, Sekossounon
    Wachinou, Ablo Prudence
    Merle, Corinne Simone Colette
    Bekou, Kossi Wilfried
    Esse, Marius
    Gossa, Severin
    Gomina, Khalil
    Baba-Moussa, Lamine
    Affolabi, Dissou
    ARCHIVES OF PHARMACY PRACTICE, 2021, 12 (03) : 66 - 72
  • [25] Decreased Dolutegravir and Efavirenz Concentrations With Preserved Virological Suppression in Patients With Tuberculosis and Human Immunodeficiency Virus Receiving High-Dose Rifampicin
    Sekaggya-Wiltshire, Christine
    Nabisere, Ruth
    Musaazi, Joseph
    Otaalo, Brian
    Aber, Florence
    Alinaitwe, Lucy
    Nampala, Juliet
    Najjemba, Letisha
    Buzibye, Allan
    Omali, Denis
    Gausi, Kamunkhwala
    Kengo, Allan
    Lamorde, Mohammed
    Aarnoutse, Rob
    Denti, Paolo
    Dooley, Kelly E.
    Sloan, Derek J.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E910 - E919
  • [26] Evaluation of High-Dose Isoniazid in MultidrugResistant Tuberculosis Treatment
    Gerussi, Valentina
    Petersen, Tania
    Bonnet, Isabelle
    Aubry, Alexandra
    Bachir, Marwa
    Gyde, Esther
    Morel, Florence
    Poignon, Corentin
    Rached, Brigitte
    Pourcher, Valerie
    Rioux, Christophe
    Vallois, Dorothee
    Veziris, Nicolas
    Robert, Jerome
    Guglielmetti, Lorenzo
    EMERGING INFECTIOUS DISEASES, 2025, 31 (03) : 633 - 635
  • [27] RESTRAINT IN USE OF HIGH-DOSE FLUORIDES TO TREAT SKELETAL DISORDERS
    MARX, SJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 240 (15): : 1630 - 1631
  • [28] Pharmacokinetic study of high-dose oral rifampicin in critically Ill patients with multidrug-resistant Acinetobacter baumannii infection
    Hossein Karballaei-Mirzahosseini
    Romina Kaveh-Ahangaran
    Bita Shahrami
    Mohammad Reza Rouini
    Atabak Najafi
    Arezoo Ahmadi
    Sima Sadrai
    Amirmahdi Mojtahedzadeh
    Farhad Najmeddin
    Mojtaba Mojtahedzadeh
    DARU Journal of Pharmaceutical Sciences, 2022, 30 : 311 - 322
  • [29] Pharmacokinetic study of high-dose oral rifampicin in critically Ill patients with multidrug-resistant Acinetobacter baumannii infection
    Karballaei-Mirzahosseini, Hossein
    Kaveh-Ahangaran, Romina
    Shahrami, Bita
    Rouini, Mohammad Reza
    Najafi, Atabak
    Ahmadi, Arezoo
    Sadrai, Sima
    Mojtahedzadeh, Amirmahdi
    Najmeddin, Farhad
    Mojtahedzadeh, Mojtaba
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 30 (02) : 311 - 322
  • [30] The safety and efficacy of high-dose daptomycin combined with rifampicin for the treatment of osteoarticular infections
    Roussos, Constantinos
    Alves, Philippe
    Francescato, Maruschka
    Muller, Daniel
    Vaudaux, Pierre
    Jugun, Kheeldass
    Uckay, Ilker
    SWISS MEDICAL WEEKLY, 2013, 143 : 50S - 50S
12345